Does Electroconvulsive Therapy (ECT) increase intra-abdominal pressure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, electroconvulsive therapy (ECT) can temporarily increase intraabdominal pressure during the procedure, but the use of muscle relaxants like succinylcholine or rocuronium significantly reduces this effect. This occurs primarily during the tonic-clonic seizure phase of ECT when generalized muscle contractions take place throughout the body, including the abdominal muscles. The increase in intraabdominal pressure is transient, lasting only for the duration of the induced seizure (typically 30-60 seconds) 1. This physiological response is similar to what occurs during a spontaneous seizure, where muscle contractions can increase pressure in various body compartments.

Key Considerations

  • Modern ECT practice includes the use of muscle relaxants like succinylcholine (typically 0.5-1.0 mg/kg) administered just before the electrical stimulus, which significantly reduces the intensity of muscle contractions and consequently minimizes the increase in intraabdominal pressure 2, 3, 4.
  • The dose of succinylcholine required to provide adequate muscle relaxation during electroconvulsive therapy can vary, with some studies suggesting a dose of 0.9 mg/kg 3 or 1 mg/kg 4 for optimal motor seizure modification.
  • Alternative muscle relaxants like rocuronium can also be used, with a dose of 0.3-0.6 mg/kg providing similar results in terms of seizure variables and clinical outcomes 1.
  • Anesthesiologists and psychiatrists typically evaluate the risks of increased intraabdominal pressure during pre-ECT assessments and may modify the anesthetic approach or muscle relaxant dosing accordingly, especially for patients with conditions that could be exacerbated by increased intraabdominal pressure, such as abdominal aortic aneurysms, recent abdominal surgery, or certain hernias.

Clinical Implications

  • The use of muscle relaxants during ECT is crucial to minimize the increase in intraabdominal pressure and ensure a safe and effective procedure.
  • The choice of muscle relaxant and dosage should be individualized based on patient factors and the specific ECT protocol being used.
  • Close monitoring of patients during ECT is essential to quickly identify and manage any potential complications related to increased intraabdominal pressure.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.